Selected research
Market Structure
Global Orexin Receptor Type 2 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Orexin Receptor Type 2 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Orexin Receptor Type 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Orexin Receptor Type 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Orexin Receptor Type 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Orexin Receptor Type 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Orexin Receptor Type 2 include Yangtze River Pharmaceutical Group, Eisai Co Ltd, Johnson & Johnson, Merck & Co Inc, OptiNose US Inc, Idorsia Ltd, Heptares Therapeutics Ltd, Evotec AG and Actelion Pharmaceuticals Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Orexin Receptor Type 2 market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Orexin Receptor Type 2 and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Orexin Receptor Type 2 revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Orexin Receptor Type 2 market size, projected growth trends, production technologies, key applications, and end-use industries.
Orexin Receptor Type 2 Segment by Company
Yangtze River Pharmaceutical Group
Eisai Co Ltd
Johnson & Johnson
Merck & Co Inc
OptiNose US Inc
Idorsia Ltd
Heptares Therapeutics Ltd
Evotec AG
Actelion Pharmaceuticals Ltd
Orexin Receptor Type 2 Segment by Type
HTL-6641
MK-8133
OPN-021
YNT-185
Lemborexant
Others
Orexin Receptor Type 2 Segment by Application
Major Depressive Disorder
Sleep Disorders
Narcolepsy
Insomnia
Orexin Receptor Type 2 Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Orexin Receptor Type 2 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Orexin Receptor Type 2 and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Orexin Receptor Type 2.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Orexin Receptor Type 2 in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Orexin Receptor Type 2 industry.
Chapter 3: Detailed analysis of Orexin Receptor Type 2 companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Orexin Receptor Type 2revenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- HTL-6641
- MK-8133
- OPN-021
- YNT-185
- Lemborexant
- Others
Applications
- Major Depressive Disorder
- Sleep Disorders
- Narcolepsy
- Insomnia
Companies covered
- Yangtze River Pharmaceutical Group
- Eisai Co Ltd
- Johnson & Johnson
- Merck & Co Inc
- OptiNose US Inc
- Idorsia Ltd
- Heptares Therapeutics Ltd
- Evotec AG
- Actelion Pharmaceuticals Ltd
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Orexin Receptor Type 2 Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 HTL-6641
- 1.2.3 MK-8133
- 1.2.4 OPN-021
- 1.2.5 YNT-185
- 1.2.6 Lemborexant
- 1.2.7 Others
- 1.3 Market Analysis by Application
- 1.3.1 Global Orexin Receptor Type 2 Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Major Depressive Disorder
- 1.3.3 Sleep Disorders
- 1.3.4 Narcolepsy
- 1.3.5 Insomnia
- 1.4 Global Market Growth Prospects
- 1.5 Global Orexin Receptor Type 2 Growth Trends by Region
- 1.5.1 Global Orexin Receptor Type 2 Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Orexin Receptor Type 2 Market Size by Region (2021-2026)
- 1.5.3 Orexin Receptor Type 2 Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Orexin Receptor Type 2 Market Dynamics
- 2.1 Orexin Receptor Type 2 Industry Trends
- 2.2 Orexin Receptor Type 2 Industry Drivers
- 2.3 Orexin Receptor Type 2 Industry Opportunities and Challenges
- 2.4 Orexin Receptor Type 2 Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Orexin Receptor Type 2 Revenue by Company (2021-2026)
- 3.2 Global Orexin Receptor Type 2 Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Orexin Receptor Type 2 Key Company Head office and Area Served
- 3.4 Global Orexin Receptor Type 2 Company, Product Type & Application
- 3.5 Global Orexin Receptor Type 2 Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Orexin Receptor Type 2 Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Orexin Receptor Type 2 Players Market Share by Revenue in 2025
- 3.6.3 2025 Orexin Receptor Type 2 Tier 1, Tier 2, and Tier 3
4 Orexin Receptor Type 2 Market by Type
- 4.1 Global Orexin Receptor Type 2 Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Orexin Receptor Type 2 Market Size by Type (2021-2032)
- 4.3 Global Orexin Receptor Type 2 Market Size Share by Type (2021-2032)
5 Orexin Receptor Type 2 Market by Application
- 5.1 Global Orexin Receptor Type 2 Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Orexin Receptor Type 2 Market Size by Application (2021-2032)
- 5.3 Global Orexin Receptor Type 2 Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Yangtze River Pharmaceutical Group
- 6.1.1 Yangtze River Pharmaceutical Group Company Information
- 6.1.2 Yangtze River Pharmaceutical Group Business Overview
- 6.1.3 Yangtze River Pharmaceutical Group Orexin Receptor Type 2 Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Yangtze River Pharmaceutical Group Orexin Receptor Type 2 Product Portfolio
- 6.1.5 Yangtze River Pharmaceutical Group Recent Developments
- 6.2 Eisai Co Ltd
- 6.2.1 Eisai Co Ltd Company Information
- 6.2.2 Eisai Co Ltd Business Overview
- 6.2.3 Eisai Co Ltd Orexin Receptor Type 2 Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Eisai Co Ltd Orexin Receptor Type 2 Product Portfolio
- 6.2.5 Eisai Co Ltd Recent Developments
- 6.3 Johnson & Johnson
- 6.3.1 Johnson & Johnson Company Information
- 6.3.2 Johnson & Johnson Business Overview
- 6.3.3 Johnson & Johnson Orexin Receptor Type 2 Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Johnson & Johnson Orexin Receptor Type 2 Product Portfolio
- 6.3.5 Johnson & Johnson Recent Developments
- 6.4 Merck & Co Inc
- 6.4.1 Merck & Co Inc Company Information
- 6.4.2 Merck & Co Inc Business Overview
- 6.4.3 Merck & Co Inc Orexin Receptor Type 2 Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Merck & Co Inc Orexin Receptor Type 2 Product Portfolio
- 6.4.5 Merck & Co Inc Recent Developments
- 6.5 OptiNose US Inc
- 6.5.1 OptiNose US Inc Company Information
- 6.5.2 OptiNose US Inc Business Overview
- 6.5.3 OptiNose US Inc Orexin Receptor Type 2 Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 OptiNose US Inc Orexin Receptor Type 2 Product Portfolio
- 6.5.5 OptiNose US Inc Recent Developments
- 6.6 Idorsia Ltd
- 6.6.1 Idorsia Ltd Company Information
- 6.6.2 Idorsia Ltd Business Overview
- 6.6.3 Idorsia Ltd Orexin Receptor Type 2 Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Idorsia Ltd Orexin Receptor Type 2 Product Portfolio
- 6.6.5 Idorsia Ltd Recent Developments
- 6.7 Heptares Therapeutics Ltd
- 6.7.1 Heptares Therapeutics Ltd Company Information
- 6.7.2 Heptares Therapeutics Ltd Business Overview
- 6.7.3 Heptares Therapeutics Ltd Orexin Receptor Type 2 Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Heptares Therapeutics Ltd Orexin Receptor Type 2 Product Portfolio
- 6.7.5 Heptares Therapeutics Ltd Recent Developments
- 6.8 Evotec AG
- 6.8.1 Evotec AG Company Information
- 6.8.2 Evotec AG Business Overview
- 6.8.3 Evotec AG Orexin Receptor Type 2 Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Evotec AG Orexin Receptor Type 2 Product Portfolio
- 6.8.5 Evotec AG Recent Developments
- 6.9 Actelion Pharmaceuticals Ltd
- 6.9.1 Actelion Pharmaceuticals Ltd Company Information
- 6.9.2 Actelion Pharmaceuticals Ltd Business Overview
- 6.9.3 Actelion Pharmaceuticals Ltd Orexin Receptor Type 2 Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Actelion Pharmaceuticals Ltd Orexin Receptor Type 2 Product Portfolio
- 6.9.5 Actelion Pharmaceuticals Ltd Recent Developments
7 North America
- 7.1 North America Orexin Receptor Type 2 Market Size (2021-2032)
- 7.2 North America Orexin Receptor Type 2 Market Size by Type
- 7.2.1 North America Orexin Receptor Type 2 Market Size by Type (2021-2026)
- 7.2.2 North America Orexin Receptor Type 2 Market Size by Type (2027-2032)
- 7.2.3 North America Orexin Receptor Type 2 Market Share by Type (2021-2032)
- 7.3 North America Orexin Receptor Type 2 Market Size by Application
- 7.3.1 North America Orexin Receptor Type 2 Market Size by Application (2021-2026)
- 7.3.2 North America Orexin Receptor Type 2 Market Size by Application (2027-2032)
- 7.3.3 North America Orexin Receptor Type 2 Market Share by Application (2021-2032)
- 7.4 North America Orexin Receptor Type 2 Market Size by Country
- 7.4.1 North America Orexin Receptor Type 2 Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Orexin Receptor Type 2 Market Size by Country (2021-2026)
- 7.4.3 North America Orexin Receptor Type 2 Market Size by Country (2027-2032)
- 7.4.4 North America Orexin Receptor Type 2 Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Orexin Receptor Type 2 Market Size (2021-2032)
- 8.2 Europe Orexin Receptor Type 2 Market Size by Type
- 8.2.1 Europe Orexin Receptor Type 2 Market Size by Type (2021-2026)
- 8.2.2 Europe Orexin Receptor Type 2 Market Size by Type (2027-2032)
- 8.2.3 Europe Orexin Receptor Type 2 Market Share by Type (2021-2032)
- 8.3 Europe Orexin Receptor Type 2 Market Size by Application
- 8.3.1 Europe Orexin Receptor Type 2 Market Size by Application (2021-2026)
- 8.3.2 Europe Orexin Receptor Type 2 Market Size by Application (2027-2032)
- 8.3.3 Europe Orexin Receptor Type 2 Market Share by Application (2021-2032)
- 8.4 Europe Orexin Receptor Type 2 Market Size by Country
- 8.4.1 Europe Orexin Receptor Type 2 Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Orexin Receptor Type 2 Market Size by Country (2021-2026)
- 8.4.3 Europe Orexin Receptor Type 2 Market Size by Country (2027-2032)
- 8.4.4 Europe Orexin Receptor Type 2 Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Orexin Receptor Type 2 Market Size (2021-2032)
- 9.2 China Orexin Receptor Type 2 Market Size by Type
- 9.2.1 China Orexin Receptor Type 2 Market Size by Type (2021-2026)
- 9.2.2 China Orexin Receptor Type 2 Market Size by Type (2027-2032)
- 9.2.3 China Orexin Receptor Type 2 Market Share by Type (2021-2032)
- 9.3 China Orexin Receptor Type 2 Market Size by Application
- 9.3.1 China Orexin Receptor Type 2 Market Size by Application (2021-2026)
- 9.3.2 China Orexin Receptor Type 2 Market Size by Application (2027-2032)
- 9.3.3 China Orexin Receptor Type 2 Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Orexin Receptor Type 2 Market Size (2021-2032)
- 10.2 Asia Orexin Receptor Type 2 Market Size by Type
- 10.2.1 Asia Orexin Receptor Type 2 Market Size by Type (2021-2026)
- 10.2.2 Asia Orexin Receptor Type 2 Market Size by Type (2027-2032)
- 10.2.3 Asia Orexin Receptor Type 2 Market Share by Type (2021-2032)
- 10.3 Asia Orexin Receptor Type 2 Market Size by Application
- 10.3.1 Asia Orexin Receptor Type 2 Market Size by Application (2021-2026)
- 10.3.2 Asia Orexin Receptor Type 2 Market Size by Application (2027-2032)
- 10.3.3 Asia Orexin Receptor Type 2 Market Share by Application (2021-2032)
- 10.4 Asia Orexin Receptor Type 2 Market Size by Country
- 10.4.1 Asia Orexin Receptor Type 2 Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Orexin Receptor Type 2 Market Size by Country (2021-2026)
- 10.4.3 Asia Orexin Receptor Type 2 Market Size by Country (2027-2032)
- 10.4.4 Asia Orexin Receptor Type 2 Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Orexin Receptor Type 2 Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Orexin Receptor Type 2 Market Size by Type
- 11.2.1 South America, Middle East & Africa Orexin Receptor Type 2 Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Orexin Receptor Type 2 Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Orexin Receptor Type 2 Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Orexin Receptor Type 2 Market Size by Application
- 11.3.1 South America, Middle East & Africa Orexin Receptor Type 2 Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Orexin Receptor Type 2 Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Orexin Receptor Type 2 Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Orexin Receptor Type 2 Market Size by Country
- 11.4.1 South America, Middle East & Africa Orexin Receptor Type 2 Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Orexin Receptor Type 2 Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Orexin Receptor Type 2 Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Orexin Receptor Type 2 Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst